L.B. Bohle Will Exhibit QbCon 1 Platform at CPHI 2026
The pharmaceutical manufacturing system will be displayed to demonstrate continuous production capabilities.
Updated on Sept. 29, 2026 in Quantum Computing
L.B. Bohle Maschinen und Verfahren GmbH will present its QbCon 1 granulation platform at the CPHI Milan 2026 exhibition. The laboratory-scale system is designed for continuous wet granulation and drying processes.
Why it matters
This showcase highlights current developments in continuous manufacturing technology for oral solid dosage forms. The platform aims to address throughput requirements for specialized pharmaceutical research and development environments.
The QbCon 1 system supports continuous throughput from 0.5 to 2.5 kg/h. It utilizes a patented fluidised bed dryer—a process where solid particles are suspended in an upward-flowing gas stream to improve heat transfer—to facilitate efficient moisture removal.
The players
L.B. Bohle Maschinen und Verfahren GmbH
A German manufacturer specializing in pharmaceutical production machinery including granulation, coating, and handling systems.
The details
The QbCon 1 combines a fluidised bed dryer with a design optimized for a narrow residence time distribution, which ensures consistency in material processing. To maintain continuous operation, the system features fully automatic filter cleaning throughout the drying process. This automation prevents clogging during prolonged granulation sessions, which is critical for maintaining consistent throughput in laboratory settings.
Timeline
CPHI Worldwide Milan will take place in 2026.
The Tech Race
The presentation of the QbCon 1 continuous granulation platform follows the industry trend of shifting from batch processing to continuous production. L.B. Bohle is positioning this laboratory-scale unit as a flexible tool in the broader race to streamline oral solid dose manufacturing.
Industry professionals can view the QbCon 1 system at booth 9F34 in Hall 9 during the CPHI Milan 2026 event. The platform is targeted specifically at laboratory environments requiring low-throughput continuous granulation.
The takeaway
The event serves as a platform to observe advancements in continuous oral solid dose manufacturing. Interested parties should monitor the CPHI Milan 2026 schedule for specific technical demonstrations occurring throughout the exhibition.
Further reading
For more information on manufacturing systems and scaling, visit /tech/quantum-computing/.
Source note: This article includes information reported by Manufacturingchemist.
